These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6765530)

  • 21. Receptor binding studies and clinical effects of human insulin (recombinant DNA): studies in patients with newly diagnosed type i diabetes, type II diabetes, insulin resistance (type A and type B), insulin antibodies, insulin allergy, and "brittle" diabetes.
    Schlüter KJ; Kerp L
    Diabetes Care; 1982; 5 Suppl 2():152-60. PubMed ID: 6765528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgE-mediated allergy to recombinant human insulin in a diabetic.
    Baur X; Bossert J; Koops F
    Allergy; 2003 Jul; 58(7):676-8. PubMed ID: 12823131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of primary and generalized allergy to human insulin with no history of any prior insulin exposure.
    Takuma H; Kawagishi T; Kyogoku I; Okuno Y; Nishizawa Y; Morii H
    Diabetes Res Clin Pract; 1995 Oct; 30(1):69-73. PubMed ID: 8745208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of NPH human insulin (recombinant DNA) and NPH bovine insulin in diabetic subjects.
    Marre M; Tabbi-Anneni A; Tabbi-Anneni H; Assan R
    Diabetes Care; 1982; 5 Suppl 2():63-6. PubMed ID: 6765544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic improvement resulting from the transfer of animal insulin-treated diabetic subjects to human insulin (recombinant DNA).
    Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ
    Diabetes Care; 1982; 5 Suppl 2():107-13. PubMed ID: 6765519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergy to human insulin and specific immunotherapy with glargine; case report with review of literature.
    Hasani-Ranjbar S; Fazlollahi MR; Mehri A; Larijani B
    Acta Diabetol; 2012 Feb; 49(1):69-73. PubMed ID: 21279523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of insulin allergy: the crystalline human insulin may mask its antigenicity.
    Takatsuki H; Ishii H; Yamauchi T; Nakashima N; Nagase S; Hisatomi A; Umeda F; Nawata H
    Diabetes Res Clin Pract; 1991 May; 12(2):137-9. PubMed ID: 1879305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and allergenic potential of animal and human insulins.
    Schernthaner G
    Diabetes Care; 1993 Dec; 16 Suppl 3():155-65. PubMed ID: 8299472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaphylaxis to protamine masquerading as an insulin allergy.
    Kim R
    Del Med J; 1993 Jan; 65(1):17-23. PubMed ID: 8454092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged desensitization required for treatment of generalized allergy to human insulin.
    Thompson DM; Ronco JJ
    Diabetes Care; 1993 Jun; 16(6):957-8. PubMed ID: 8325221
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous allergy to human (recombinant DNA) insulin.
    Grammer LC; Metzger BE; Patterson R
    JAMA; 1984 Mar; 251(11):1459-60. PubMed ID: 6366262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
    Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
    Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous antihistamine injection is effective to control a local allergic reaction to human insulin.
    Imakado S; Hamada K; Atsumi Y
    Diabetes Res Clin Pract; 2009 Sep; 85(3):e42-3. PubMed ID: 19520450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A practical, clinical approach to the assessment and management of suspected insulin allergy.
    Jacquier J; Chik CL; Senior PA
    Diabet Med; 2013 Aug; 30(8):977-85. PubMed ID: 23601039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin allergy in clinical practice.
    Skelly AH; Van Son AR
    Nurse Pract; 1987 Apr; 12(4):14-8, 23. PubMed ID: 3554035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of omalizumab in insulin hypersensitivity: a case report and review of the literature.
    Mishra S; Connors L; Tugwell B
    Diabet Med; 2018 May; 35(5):663-666. PubMed ID: 29381818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteins: chymopapain and insulin.
    Grammer LC; Patterson R
    J Allergy Clin Immunol; 1984 Oct; 74(4 Pt 2):635-40. PubMed ID: 6386938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary systemic allergy to human insulin: recurrence of generalized urticaria after successful desensitization.
    Chng HH; Leong KP; Loh KC
    Allergy; 1995 Dec; 50(12):984-7. PubMed ID: 8834829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting insulin allergy in a diabetic child.
    Mastrorilli C; Rizzuti L; Cangelosi AM; Iovane B; Chiari G; Caffarelli C
    Int J Immunopathol Pharmacol; 2017 Jun; 30(2):174-177. PubMed ID: 28368217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin allergy in a 19-month-old boy with newly diagnosed diabetes mellitus.
    Wishner KL; Fisher LK; Kumar D
    Pediatrics; 1982 Jul; 70(1):137-8. PubMed ID: 7045803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.